Skip to content

Single Nuclei Sequencing in Human Skeletal Muscle After Unloading

Single Nuclei Sequencing in Human Skeletal Muscle After Unloading

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05801185
Acronym
ULLS23
Enrollment
20
Registered
2023-04-06
Start date
2023-03-05
Completion date
2026-12-01
Last updated
2026-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unilateral Lower Limb Suspension

Keywords

ULLS, single nuclei RNA sequencing, Skeletal muscle

Brief summary

Injuries often require people to undergo some degree of limb immobilization. This comes at a high cost in terms of muscle mass and function losses. At the molecular level, it is completely unknown how the different cells in the muscle respond to this complete lack of mechanical stimuli. The investigators will explore cell type specific changes in skeletal muscle after a short period of unloading, and specifically examine the behavior of myogenic stem cells with particular attention to potential unloading-induced maturation into fast- or slow-twitch muscle fibers. Twenty healthy young participants will perform a 5-day Unilateral Lower Limb Suspension (ULLS) intervention, where one leg is continuously subjected to unloading, i.e., lack of mechanical stimuli. Before and after the ULLS period, participants will perform muscle function testing and MRI scans to assess muscle size in the lower limbs. Immediately after the ULLS, two muscle biopsies will be obtained, one from each leg. The tissue will be employed for single-nuclei RNA sequencing analysis and immunohistochemistry experiments. This project will be the first to analyze cell type specific changes induced by complete, short-term lack of mechanical stimuli in skeletal muscle. This will add a new dimension to the understanding of the processes directing this type of muscle atrophy (i.e., muscle loss in otherwise healthy individuals) and thus help to develop effective countermeasures to offset muscle changes.

Interventions

Participants will perform a 5-day unloading intervention using the ULLS model. Short-length crutches, aided by handgrip and forearm support distal to the elbow will be used to assist in any upright or ambulatory activity. One foot (randomized in a counterbalance manner) will be equipped with a shoe having a 10-cm thick sole, which permits the unloaded limb to move passively about the hip joint while adopting a near straight position.

Sponsors

Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Participants will perform a 5-day unloading intervention using the ULLS model. Short-length crutches, aided by handgrip and forearm support distal to the elbow will be used to assist in any upright or ambulatory activity. One foot (randomized in a counterbalance manner) will be equipped with a shoe having a 10-cm thick sole, which permits the unloaded limb to move passively about the hip joint while adopting a near straight position.

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy young adult men and women

Exclusion criteria

* An age younger than 18 or older than 40 years * Contraindications to magnetic resonance imaging (MRI) * Contraindications to maximal intensity resistance exercise * Contraindications to unloading (i.e., ULLS) * Very high physical activity levels (determined using a standard Godin Leisure-Time Exercise Questionnaire (GLTEQ)) * Hypertension (\>140/90 mm Hg) * History of malignancy * History of coagulation dysfunction * History of musculoskeletal or neurological disorders * History of cardiovascular disease * History of cerebrovascular disease * History of respiratory disease * History of gastrointestinal disease * History of renal disease * History of past or present condition requiring long-term drug prescriptions.

Design outcomes

Primary

MeasureTime frameDescription
Single nuclei RNA sequencingImmediately after the 5-day unilateral unloading interventionSingle nuclei RNA sequencing from skeletal muscle (m. vastus lateralis) from both legs

Secondary

MeasureTime frameDescription
Muscle massBefore and immediately after the 5-day unloading interventionMuscle volume of quadriceps muscle group (and individual muscles) assessed by MRI in both legs
Concentric isokinetic torque of knee extensor musclesBefore and immediately after the 5-day unloading interventionConcentric isokinetic torque of knee extensor muscles at 30°/s, 90°/s, 180°/s and 300°/s, measured with an isokinetic dynamometer unilaterally in both legs
Isometric torque of knee extensor musclesBefore and immediately after the 5-day unloading interventionIsometric torque of knee extensor muscles at 60° knee flexion, measured with an isokinetic dynamometer unilaterally in both legs

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 1, 2026